Publications
Detailed Information
Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, So-Youn | - |
dc.contributor.author | Han, Wonshik | - |
dc.contributor.author | Lee, Jong Won | - |
dc.contributor.author | Ko, Eunyoung | - |
dc.contributor.author | Kim, Eunkyu | - |
dc.contributor.author | Yu, Jong-Han | - |
dc.contributor.author | Moon, Hyeong-Gon | - |
dc.contributor.author | Park, In Ae | - |
dc.contributor.author | Oh, Do-Youn | - |
dc.contributor.author | Im, Seock-Ah | - |
dc.contributor.author | Kim, Tae-You | - |
dc.contributor.author | Hwang, Ki-Tae | - |
dc.contributor.author | Kim, Sung-Won | - |
dc.contributor.author | Noh, Dong-Young | - |
dc.date.accessioned | 2012-05-24T07:31:15Z | - |
dc.date.available | 2012-05-24T07:31:15Z | - |
dc.date.created | 2021-01-12 | - |
dc.date.created | 2021-01-12 | - |
dc.date.created | 2021-01-12 | - |
dc.date.issued | 2009-05 | - |
dc.identifier.citation | Annals of Surgical Oncology, Vol.16 No.5, pp.1112-1121 | - |
dc.identifier.issn | 1068-9265 | - |
dc.identifier.other | 120637 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76442 | - |
dc.description.abstract | We sought to determine the significance of Ki-67, one of the tumor cell proliferation markers, as a useful prognostic factor in early breast cancer. A total of 1080 consecutive patients with stage I or II breast cancer that underwent surgery between 1998 and 2003 were enrolled. Patients were categorized on the basis of the 2007 St. Gallen consensus and Adjuvant! Online. The expression of Ki-67 in the tumor was assayed by immunohistochemistry (cutoff value, 10%). Univariate analysis determined that tumor size, lymph node involvement, histologic grade, estrogen receptor, progesterone receptor, bcl-2, and Ki-67 (a parts per thousand yen10%) were statistically significant for both overall survival (OS) and distant metastasis-free survival (DFS). Of these factors, lymph node involvement and high Ki-67 expression were identified as independent prognostic factors for OS and DFS on the basis of multivariate analysis. The survivals of intermediate- and high-risk groups according to 2007 St. Gallen consensus were further separated by Ki-67 expression level (5-year DFS rate = 91.9% vs. 86.3% for Ki-67 < 10% and a parts per thousand yen10%, respectively in intermediate-risk group (P = .01); 5-year DFS rate = 82.5% vs. 61.4% for Ki-67 < 10% and a parts per thousand yen10%, respectively in high-risk group (P = .01)). The survivals of low- and high-risk groups according to Adjuvant! Online were further separated by Ki-67 expression level (5-year DFS rate = 97.8% vs. 89.5% for Ki-67 < 10% and a parts per thousand yen10%, respectively in low-risk group (P = .02); 5-year DFS rate = 9.4% vs. 82.6% for Ki-67 < 10% and a parts per thousand yen10% in high-risk group (P = .005)). Ki-67 is an independent prognostic factor for DFS and OS in early breast cancer and can provide additional prognostic information on the risk stratification with the use of the 2007 St. Gallen consensus and Adjuvant! Online. | - |
dc.language | 영어 | - |
dc.language.iso | en | ko_KR |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 임석아 | - |
dc.identifier.doi | 10.1245/s10434-009-0334-7 | - |
dc.citation.journaltitle | Annals of Surgical Oncology | - |
dc.description.citedreference | Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364 | - |
dc.description.citedreference | Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271 | - |
dc.description.citedreference | Ahn SH, 2007, J CLIN ONCOL, V25, P2360, DOI 10.1200/JCO.2006.10.3754 | - |
dc.description.citedreference | de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756 | - |
dc.description.citedreference | Dowsett M, 2007, J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020 | - |
dc.description.citedreference | Railo M, 2007, TUMOR BIOL, V28, P45, DOI 10.1159/000097702 | - |
dc.description.citedreference | Buyse M, 2006, J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329 | - |
dc.description.citedreference | Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352 | - |
dc.description.citedreference | Abe O, 2005, LANCET, V365, P1687 | - |
dc.description.citedreference | Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178 | - |
dc.description.citedreference | Wang YX, 2005, LANCET, V365, P671 | - |
dc.description.citedreference | Jacquemier J, 2005, CANCER RES, V65, P767 | - |
dc.description.citedreference | Erdem O, 2005, TUMORI, V91, P46 | - |
dc.description.citedreference | Paik S, 2004, NEW ENGL J MED, V351, P2817 | - |
dc.description.citedreference | Sun JM, 2004, CANCER, V101, P2516, DOI 10.1002/cncr.20665 | - |
dc.description.citedreference | Caly M, 2004, ANTICANCER RES, V24, P3283 | - |
dc.description.citedreference | Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576 | - |
dc.description.citedreference | Volpi A, 2003, J CLIN ONCOL, V21, P2708, DOI 10.1200/JCO.2003.04.008 | - |
dc.description.citedreference | Roila F, 2003, ANN ONCOL, V14, P843, DOI 10.1093/annonc/mdg256 | - |
dc.description.citedreference | Trihia H, 2003, CANCER, V97, P1321 | - |
dc.description.citedreference | van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999 | - |
dc.description.citedreference | Palazzi M, 2002, TUMORI, V88, P503 | - |
dc.description.citedreference | Boyages J, 2002, BRIT J SURG, V89, P789 | - |
dc.description.citedreference | Spyratos F, 2002, CANCER, V94, P2151, DOI 10.1002/cncr.10458 | - |
dc.description.citedreference | Billgren AM, 2002, BREAST CANCER RES TR, V71, P161 | - |
dc.description.citedreference | Iwamoto E, 2001, JPN J CLIN ONCOL, V31, P259 | - |
dc.description.citedreference | Ravdin PM, 2001, J CLIN ONCOL, V19, P980 | - |
dc.description.citedreference | Lau R, 2001, INT J ONCOL, V18, P17 | - |
dc.description.citedreference | Rudolph P, 1999, J NATL CANCER I, V91, P271 | - |
dc.description.citedreference | Thor AD, 1999, J CLIN ONCOL, V17, P470 | - |
dc.description.citedreference | Molino A, 1997, INT J CANCER, V74, P433 | - |
dc.description.citedreference | Pietilainen T, 1996, J CANCER RES CLIN, V122, P687 | - |
dc.description.citedreference | Brown RW, 1996, CLIN CANCER RES, V2, P585 | - |
dc.description.citedreference | CHER ML, 1995, PROSTATE, V26, P87 | - |
dc.description.citedreference | VERONESE SM, 1993, CANCER, V71, P3926 | - |
dc.description.citedreference | GALEA MH, 1992, BREAST CANCER RES TR, V22, P207 | - |
dc.description.citedreference | ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403 | - |
dc.description.citedreference | GERDES J, 1991, AM J PATHOL, V138, P867 | - |
dc.description.citedreference | QUIRKE P, 1986, J PATHOL, V149, P79 | - |
dc.description.citedreference | DEAN PN, 1984, CELL TISSUE KINET, V17, P427 | - |
dc.description.citedreference | MALAISE EP, 1973, EUR J CANCER, V9, P305 | - |
dc.description.tc | 19 | - |
dc.identifier.wosid | 000264878900009 | - |
dc.identifier.scopusid | 2-s2.0-64249146434 | - |
dc.citation.endpage | 1121 | - |
dc.citation.number | 5 | - |
dc.citation.startpage | 1112 | - |
dc.citation.volume | 16 | - |
dc.identifier.sci | 000264878900009 | - |
dc.description.isOpenAccess | Y | - |
dc.contributor.affiliatedAuthor | Han, Wonshik | - |
dc.contributor.affiliatedAuthor | Park, In Ae | - |
dc.contributor.affiliatedAuthor | Oh, Do-Youn | - |
dc.contributor.affiliatedAuthor | Im, Seock-Ah | - |
dc.contributor.affiliatedAuthor | Kim, Tae-You | - |
dc.contributor.affiliatedAuthor | Kim, Sung-Won | - |
dc.contributor.affiliatedAuthor | Noh, Dong-Young | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | INTERNATIONAL EXPERT CONSENSUS | - |
dc.subject.keywordPlus | CELL-PROLIFERATION | - |
dc.subject.keywordPlus | MONOCLONAL-ANTIBODY | - |
dc.subject.keywordPlus | CLINICAL-PRACTICE | - |
dc.subject.keywordPlus | PRIMARY THERAPY | - |
dc.subject.keywordPlus | PHASE FRACTION | - |
dc.subject.keywordPlus | MITOTIC INDEX | - |
dc.subject.keywordPlus | MARKERS | - |
dc.subject.keywordPlus | VALIDATION | - |
dc.subject.keywordPlus | SURVIVAL | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.